XBIT XBiotech, Inc.

13.52-0.63 (-4.45%)
Close: November 21, 2019

Quote

Previous Close
$13.52
Day Range
$13.31-$14.25
52 Week Range
$3.66-$15.32
Volume
209,666
Avg Volume
147,481
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$555.50M
Enterprise Value (EV)
$565.56M
PE Ratio
-
EV/EBITDA
-30.47
Price/Sales
-
Price/Book
13.42
PEG Ratio
-

Financials

Revenue
-
Gross Profit
-$2.43M
EBITDA
-$18.56M
EPS, ttm
-$0.64
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
-
Debt to Equity
-
Debt
$25.88M
Cash
$15.82M
Net Debt
$10.06M

Performance

Beta
0.29
200 Day Moving Avg
$8.97
50 Day Moving Avg
$10.22
52 Week Change
229.07%
YTD Change
170.31%
1 Month Change
44.54%
3 Month Change
71.93%
6 Month Change
53.97%
1 Year Change
229.07%
2 Year Change
242.62%
5 Year Change
-39.14%

Share Count

Shares Outstanding
41.1M
Float
17.9M
Restricted Shares
23.1M
Restricted Shares, %
56.33%

XBiotech, Inc. Company Details

Sector: Health Technology

Industry: Biotechnology

CEO: John Simard

Website: http://www.xbiotech.com

Description: XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Employees: 53